It all started with one computer. Then, at a point in time, we learned to connect it with other computers. Eventually, personalized computers emerged and individuals began to own the hardware that are helping them to do the work. Conversely, things run a little differently for software. While most
This week is, undoubtedly, an exciting week for innovations and technology. As AIMed hosted two of its subspecialty events – AIMed Surgery and ICU (Intensive Care Unit) in Miami, Florida; GITEX (Gulf Information Technology Exhibition), the biggest tech show in the Middle East, North Africa, and Sout
Artificial intelligence (AI), as believed by many, has the potential to transform medicine from sick care to predictive or even preventive care; that means individuals' needs are attended before they address themselves as “patients”. As such, the current AI hype had not only given birth to an overwh
As much as AIMed would love to involve everyone ranging from medical professionals, technology experts, business partners, and patients to explore the impact of artificial intelligence (AI) and related new technologies on healthcare and medicine; medical students have been the trickiest to do so.&nb
After AIMed Cardiology and Radiology which took place this June in Chicago, Illinois. The latest round of AIMed sub-specialty events: AIMed Surgery and ICU are happening today (7 October) and tomorrow (8 October) respectively in Miami, Florida. These fields of work are chosen for a reason. Some of t
In this year’s AIMed Europe took place in central London between 17 and 19 September, representatives from two large insurance firms – Reza Khorshidi, Chief Scientist, Global, AIG and Dr. Sneh Khemka, President of International Population Health solutions, Aetna International, detailed how artificia
Microsoft UK published its latest artificial intelligence (AI) report entitled “Accelerating competitive advantage with AI: How organizations are moving from experimentation to business impact” yesterday (1 October). The report can be regarded as the continuation of its counterpart published in
As mentioned from time and again, 2019 is an eventful year for AIMed as we are not only hosting our annual flagship meeting in Europe (17 – 19 September), Australia (12 – 13 November), and North America (11 – 14 December), but we are also focusing on sub-specialty meetings for an insi
The US Food and Drug Administration (FDA) released a new set of guidance documents last Thursday (26 September) to clarify its stand on regulating clinical decision support (CDS) tools including artificial intelligence (AI) driven and mobile health software that assist medical professionals in